购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空

5-Fluorouracil

Rating icon 很棒
产品编号 T0984Cas号 51-21-8
别名 氟尿嘧啶, NSC 19893, Fluorouracil, 5-氟脲嘧啶, 5-FU, 5-Fluoracil

5-Fluorouracil (5-FU) 是一种尿嘧啶类似物,一种 DNA 合成抑制剂。5-Fluorouracil 具有抗肿瘤活性,通过抑制胸苷酸合成酶影响嘧啶的合成。5-Fluorouracil 可以引起细胞凋亡和自噬。

5-Fluorouracil

5-Fluorouracil

Rating icon 很棒
纯度: 100%
产品编号 T0984 别名 氟尿嘧啶, NSC 19893, Fluorouracil, 5-氟脲嘧啶, 5-FU, 5-FluoracilCas号 51-21-8

5-Fluorouracil (5-FU) 是一种尿嘧啶类似物,一种 DNA 合成抑制剂。5-Fluorouracil 具有抗肿瘤活性,通过抑制胸苷酸合成酶影响嘧啶的合成。5-Fluorouracil 可以引起细胞凋亡和自噬。

规格价格库存数量
200 mg¥ 291现货
1 g¥ 375现货
5 g¥ 696现货
1 mL x 10 mM (in DMSO)¥ 418现货
大包装 & 定制
加入购物车
实验操作小课堂
查看更多

"5-Fluorouracil"的相关化合物库

选择批次:
纯度:99.98%
联系我们获取更多批次信息
TargetMol 的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。

产品介绍

生物活性
产品描述
5-Fluorouracil (5-FU) is a uracil analog, an inhibitor of DNA synthesis. 5-Fluorouracil has antitumor activity and affects pyrimidine synthesis through inhibition of thymidylate synthase. 5-Fluorouracil causes apoptosis and autophagy.
体外活性
方法:人心肌细胞 HCM、人脐静脉内皮细胞 HUVE 和 人结肠癌细胞 HCT116、HT29 用 5-Fluorouracil (0.01-1000 µM) 处理 24-96 h,使用 MTT 方法检测细胞生长抑制情况。
结果:72 h 时 5-Fluorouracil 对 HCM、HUVE、PHCT116 和 HT29 细胞的 EC50 分别为 4.866 μM、3.832 μM、13.72 μM 和 106.8 μM。[1]
方法:平滑肌细胞用 5-Fluorouracil (0.05-10 mM) 处理 24 h,使用 Flow Cytometry 方法检测细胞凋亡情况。
结果:浓度为 0.1、1 和 10mM 的 5-Fluorouracil 在处理 24 h 后诱导培养的平滑肌细胞凋亡,并且凋亡细胞从培养皿中分离。[2]
方法:人结肠癌细胞 SW620 用 5-Fluorouracil (13 μg/mL) 孵育 24-48 h,使用 ALP detection kit 检测 ALP 活性。
结果:碱性磷酸酶 (ALP) 已被用于监测某些抗癌化合物的分化效果。未处理的 SW620 细胞表现出相对较低的 ALP 活性,而在用 13μg/ml 5-FU 处理的细胞中,ALP 的活性以时间依赖的方式达到高水平。[3]
体内活性
方法:为检测体内抗肿瘤活性,将 5-Fluorouracil (10-40 mg/kg) 腹腔注射给携带小鼠腹水肝癌肿瘤 H22 的小鼠,每天一次,持续十天。
结果:10 mg/kg 的 5-Fluorouracil 抑制肿瘤生长,同时维持小鼠的免疫功能。5-Fluorouracil 可发挥低剂量、低毒的抗肿瘤作用,刺激宿主免疫系统。[4]
方法:为研究 5-Fluorouracil 诱导的肠道损伤,将 5-Fluorouracil (100-200 mg/kg) 单次腹腔注射给 BALB/c 小鼠。
结果:5-Fluorouracil 治疗的动物的体重及腹泻症状以剂量依赖的方式显著降低。5-Fluorouracil 治疗组的 occludin 和 claudin-1 蛋白的表达显著降低。5-Fluorouracil 治疗组 NF-κBp65 蛋白和 TNF-α mRNA 的表达明显高于对照组。[5]
细胞实验
After a 7-day habituation period, the mice were divided into three groups (vehicle group, dextrin group, and ED group; n = 6 mice per group) that had the same mean body weight (time of grouping was designated as day 0). Then, mice were treated by tail vein injections from day 0 to 4; mice in the dextrin and ED groups received 40 mg/kg/day of 5- fluorouracil (5-FU) injection 250 mg, while mice in the vehicle group received 10 mL/kg/day physiological saline, which was equivalent to the dose of 5-FU. Additionally, twice a day from day 0 to 6, ED group mice received 1.6 kcal/0.8 mL/day ED administered orally, while mice in the vehicle and dextrin groups received dextrin containing the same amount of calories. Body weight and food consumption were measured before administration of 5-FU and ED on days 0 and 7. Food consumption was measured with respect to each group. Mice were accommodated individually in specially prepared polycarbonate cages, and two or more fresh stools per mouse were scored as follows: 0, the stools were not crushed when pushed by human fingers; 1, the stools were crushed, but the core remained when pushed by human fingers; 2, the stools were crushed and the core did not remain when pushed by human fingers; 3, the stools were crushed and stuck to the fingers when pushed by human fingers; 4, the stools lost their shape just from being touched. Autopsies were conducted on day 7. After bleeding, the large intestine (the colon and rectum) was taken, and the length was measured. The lumen was washed with physiological saline, the excess water was wiped off, and specimens were weighed. Section 3 cm distal from the center of the large intestine was fixed with formalin for histological evaluation. Salivary glands (the submandibular gland and sublingual gland) were collected and weighed. The collected salivary glands were fixed with formalin, and after the tissue sections were prepared, they were stained with hematoxylin and eosin [3].
别名氟尿嘧啶, NSC 19893, Fluorouracil, 5-氟脲嘧啶, 5-FU, 5-Fluoracil
化学信息
分子量130.08
分子式C4H3FN2O2
CAS No.51-21-8
SmilesFC1=CNC(=O)NC1=O
密度1.53 g/cm3
储存&溶解度
存储Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度信息
10% DMSO+90% Saline: 1.3 mg/mL (9.99 mM), In vivo: Please add co-solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately.
Ethanol: 1.3 mg/mL (10 mM)
H2O: 10 mg/mL (76.8 mM), Heating at 50℃ is recommended.
DMSO: 18.33 mg/mL (140.94 mM)
溶液配制表
Ethanol/H2O/DMSO
1mg5mg10mg50mg
10 mM0.7688 mL3.8438 mL7.6876 mL38.4379 mL
H2O/DMSO
1mg5mg10mg50mg
20 mM0.3844 mL1.9219 mL3.8438 mL19.2189 mL
50 mM0.1538 mL0.7688 mL1.5375 mL7.6876 mL
DMSO
1mg5mg10mg50mg
100 mM0.0769 mL0.3844 mL0.7688 mL3.8438 mL

计算器

  • 摩尔浓度 计算器
  • 稀释 计算器
  • 配液 计算器
  • 分子量 计算器

体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:
TargetMol | Animal experiments比如您的给药剂量是 10 mg/kg ,每只动物体重 20 g ,给药体积 100 μLTargetMol | Animal experiments 一共给药动物 10 只 ,您使用的配方为 5% TargetMol | reagent DMSO+ 30%PEG300+ 5%Tween 80 + 60% ddH2O. 那么您的工作液浓度为 2 mg/mL
母液配置方法: 2 mg 药物溶于 50 μLDMSOTargetMol | reagent ( 母液浓度为 40 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:50μLDMSOTargetMol | reagent 母液,添加 300 μLPEG300TargetMol | reagent 混匀澄清,再加 50μLTween 80, 混匀澄清,再加 600μLddH2OTargetMol | reagent 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

1 请输入动物实验的基本信息
mg/kg
g
μL
2 请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
%Tween 80
%ddH2O

剂量转换

对于不同动物的给药剂量换算,您也可以参考 更多

关键词

评论列表

4个月前
5.0
Rating icon 很棒

评论内容

Related Tags: buy 5-Fluorouracil | purchase 5-Fluorouracil | 5-Fluorouracil cost | order 5-Fluorouracil | 5-Fluorouracil chemical structure | 5-Fluorouracil in vivo | 5-Fluorouracil in vitro | 5-Fluorouracil formula | 5-Fluorouracil molecular weight